Büller HR - Search Results

1

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study.

van Haaps TF, Collard D, van Osch FHM, Middeldorp S, Coppens M, de Kruif MD, Vlot EA, Douma RA, Ten Cate H, Juffermans NP, Gritters N, Vlaar AP, Reidinga AC, Heuvelmans MA, Oudkerk M, Büller HR, van den Bergh JPW, Maas A, Ten Wolde M, Simsek S; Corona Research Fund Amsterdam UMC; Beudel M, van Es N; Dutch COVID & Thrombosis Coalition. van Haaps TF, et al. Among authors: buller hr. Thromb Res. 2021 Dec;208:35-38. doi: 10.1016/j.thromres.2021.10.006. Epub 2021 Oct 15. Thromb Res. 2021. PMID: 34688100 Free PMC article. No abstract available.

2

A rebuttal: Counseling pregnant women with factor V Leiden homozygosity: use absolute instead of relative risks.

Middeldorp S, van der Meer J, Hamulyák K, Büller HR. Middeldorp S, et al. Among authors: buller hr. Thromb Haemost. 2002 Feb;87(2):360-1; author reply 361. Thromb Haemost. 2002. PMID: 11858509 No abstract available.

3

The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis.

ten Wolde M, Kraaijenhagen RA, Prins MH, Büller HR. ten Wolde M, et al. Among authors: buller hr. Arch Intern Med. 2002 Sep 9;162(16):1880-4. doi: 10.1001/archinte.162.16.1880. Arch Intern Med. 2002. PMID: 12196087

4

Travel and the risk of symptomatic venous thromboembolism.

ten Wolde M, Kraaijenhagen RA, Schiereck J, Hagen PJ, Mathijssen JJ, Mac Gillavry MR, Koopman MM, Büller HR. ten Wolde M, et al. Among authors: buller hr. Thromb Haemost. 2003 Mar;89(3):499-505. Thromb Haemost. 2003. PMID: 12624634

5

Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.

Bank I, Scavenius MP, Büller HR, Middeldorp S. Bank I, et al. Among authors: buller hr. Thromb Res. 2004;113(1):7-12. doi: 10.1016/j.thromres.2004.02.002. Thromb Res. 2004. PMID: 15081560 Clinical Trial.

6

Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism.

ten Wolde M, Söhne M, Quak E, Mac Gillavry MR, Büller HR. ten Wolde M, et al. Among authors: buller hr. Arch Intern Med. 2004 Aug 9-23;164(15):1685-9. doi: 10.1001/archinte.164.15.1685. Arch Intern Med. 2004. PMID: 15302640 Review.

7

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.

Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR. Bank I, et al. Among authors: buller hr. Arch Intern Med. 2004 Sep 27;164(17):1932-7. doi: 10.1001/archinte.164.17.1932. Arch Intern Med. 2004. PMID: 15451770

8

Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications.

Middeldorp S, van de Poel MH, Bank I, Hamulyák K, Libourel EJ, Koopman MM, Prins MH, van der Meer J, Büller HR. Middeldorp S, et al. Among authors: buller hr. Thromb Haemost. 2004 Oct;92(4):787-90. doi: 10.1160/TH04-03-0198. Thromb Haemost. 2004. PMID: 15467909

9

Biomarkers in pulmonary embolism.

Söhne M, Ten Wolde M, Büller HR. Söhne M, et al. Among authors: buller hr. Curr Opin Cardiol. 2004 Nov;19(6):558-62. doi: 10.1097/01.hco.0000138991.82347.0e. Curr Opin Cardiol. 2004. PMID: 15502498 Review.

10

Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis.

Bank I, Tick LW, Hutten BA, Kramer MH, Middeldorp S, Büller HR. Bank I, et al. Among authors: buller hr. Pathophysiol Haemost Thromb. 2003 Jul-2004 Aug;33(4):192-6. doi: 10.1159/000081507. Pathophysiol Haemost Thromb. 2003. PMID: 15583448 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

733 results

Search Page